Propel Bio Management »

Corvus Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 86k 14.58

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Vanguard Capital Management
Vivo Capital
State Street Corporation
Morgan Stanley
Deep Track Capital
Perceptive Advisors
Commodore Capital
Foresite Capital Management VI
Braidwell
Geode Capital Management
MPM Oncology Impact Management

View all funds holding Corvus Pharmaceuticals